Manufacturer that ruined 15 million Johnson & Johnson vaccine doses once got a $163 million federal contract to improve its facility: NYT
- A facility that ruined millions of
COVID-19 vaccinedoses once got a $163 million federal contract, The New York Times reports.
- 15 million doses of the Johnson & Johnson vaccine had to be thrown out due to contamination issues at the plant.
- The funds were for improvements at the facility and preparations for a potential pandemic.
A Baltimore factory that ruined 15 million doses of the Johnson & Johnson
The federal government first invested in Emergent BioSolutions - a biotech firm that's known for producing anthrax vaccines - more than eight years ago so that its Baltimore factory could be ready in case of a pandemic.But the factory has been marred with issues, The Times reported. It was previously cited by the Food and Drug Administration for a myriad of issues, including mold and cracked vials, according to the Associated Press.
"No one, including employees at Emergent, wants to see vaccines that cannot be used," the company said in a statement, adding: "Any allegation that our safety, quality, and compliance systems are not working or that we do not take these responsibilities seriously is unequivocally false."Johnson & Johnson didn't immediately return a request for comment from Insider.
- Notified new policy on rare diseases, approved budget of Rs 25 crore for treatment: Centre to HC
- Former PM Manmohan Singh admitted to AIIMS after testing positive for COVID-19
- If you are 18 years or older, you can get a COVID-19 vaccine from May 1
- India is promoting a new internet protocol— the government is offering help for websites to migrate
- SaaS unicorn Druva, which manages data for NASA, Pfizer, and GameStop, raises $147 million; valuation crosses $2 billion